Albert Bourla, Pfizer CEO (Steven Ferdman/Getty Images)
November 11, 2020 07:27 AM ESTUpdated 09:51 AM
People
Coronavirus

As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

Jason Mast

Editor

On Mon­day morn­ing, Pfiz­er an­nounced they had de­vel­oped the first ef­fec­tive Covid-19 vac­cine, the world cel­e­brat­ed, their stock jumped 13% and their CEO be­came …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times